Sarah Cannon/Colorado Blood Cancer Institute

Denver, Colorado 80218

1 studies enrolling now · 4 studies all time

What they study most

B-cell Acute Lymphoblastic Leukemia, Multiple Myeloma, Relapsed/Refractory Multiple Myeloma

Studies at this site

• Selinexor and Backbone Treatments of Multiple Myeloma Patients — Recruiting now
• Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01) — Recruiting now
• Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL) — Completed
• Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma — Stopped early